Pregnancy outcomes in Australian patients with systemic lupus erythematosus
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Sakiko Isojima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Pregnancy Outcome, Pregnancy Complications. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Systemic lupus erythematosus (SLE) affects women, with the onset of disease typically around the childbearing years.
Aims
This study examines the frequency and risk factors for adverse pregnancy outcomes (APOs) in an Australian cohort, and any disease flares during pregnancy and post partum.
Methods
Female patients with SLE enrolled in the Australian Lupus Registry and Biobank (ALRB) between January 2007 and June 2019 were studied. Self‐reported pregnancy history, including adverse foetal or maternal outcomes, was collected at the time of enrolment and updated as appropriate. Baseline demographics, clinical parameters, medication exposure and disease activity were collected. Factors associated with APO were examined using univariate and multivariate logistic regression analyses.
Results
Pregnancy history was available in 278 patients; 30% were nulliparous. Most pregnancies occurred before the diagnosis of SLE. Patients who had pregnancies after SLE diagnosis had an earlier age of diagnosis, and had fewer pregnancies. The APO rate was 44.3% in the overall cohort, with most presenting as prematurity with or without foetal growth restriction. Women with APO were also diagnosed with SLE at a younger age and had a higher prevalence of anti‐cardiolipin antibodies and hypocomplementemia. Early age of SLE diagnosis was a significant independent risk factor for APO. No increase in disease flare was observed in those who experienced APO during the observation period of ALRB.
Conclusion
This study shows a considerable incidence of APO in patients with SLE, emphasising the need for pre‐pregnancy counselling and collaboration between maternal‐foetal medicine specialists and rheumatologists, especially for women diagnosed with SLE at a younger age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
- Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
- Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia.
- Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia.
ORCID-Profile: Sakiko Isojima, Eric F Morand
Zitieren
APA
Isojima, S., Li, N., Rowson, S., Kandane-Rahtnayake, R., Koelmeyer, R., Morand, E. F., & Hoi, A. (2024). Pregnancy outcomes in Australian patients with systemic lupus erythematosus. Internal Medicine Journal. https://doi.org/10.1111/imj.16524
Vancouver
Isojima S, Li N, Rowson S, Kandane-Rahtnayake R, Koelmeyer R, Morand EF, et al. Pregnancy outcomes in Australian patients with systemic lupus erythematosus. Internal Medicine Journal. 2024. doi:10.1111/imj.16524
BibTeX
@article{Isojima2024,
author = {Isojima, Sakiko and Li, Ning and Rowson, Saskia and Kandane-Rahtnayake, Rangi and Koelmeyer, Rachel and Morand, Eric F and Hoi, Alberta},
title = {Pregnancy outcomes in Australian patients with systemic lupus erythematosus},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16524}
}
EUVIMED